We came across a bullish thesis on Kenvue Inc. on X.com by ZeeContrarian1. In this article, we will summarize the bulls’ thesis on KVUE. Kenvue Inc.'s share was trading at $16.23 as of September 30th. KVUE’s trailing and forward P/E were 21.89 and 14.81 respectively according to Yahoo Finance.
Donald Trump, despite having no medical background, has once again made headlines with controversial health advice, this time targeting prenatal care. He claimed that taking acetaminophen, the active ingredient in Tylenol, during pregnancy could cause autism and urged expectant mothers to...
Create a free account, or log in to read the full article
No credit card required.
We may use your email to send marketing emails about our services. Click here to read our privacy policy.